Cookies: Information & Consent

We have placed cookies on your device to help make this website better. Some of the cookies we use are essential for this site to work. We also use some non-essential cookies to collect information for making reports and to help us improve the site. You will find more detailled information in our Privacy Chart.

March 2020

Banook Group welcomes Turenne Santé as new investor, alongside the management

Funds obtained will enable the European leader in cardiac safety to continue its…
Read the full post
May 2018

Webinar : Advances in cardiovascular diagnostic devices for clinical trial

Tuesday, May 29th, 2018  6:00 PM CEST (Central European Time) UTC/GMT + 2…
Read the full post
April 2017

Event Participation 2017

Banook Group will attend the following exhibitions. Let’s meet there!
Read the full post
February 2017

Cardiabase by Banook Group opens subsidiary in Montreal, Canada

Group strengthens its presence in North American market, aiming for 30% growth in…
Read the full post
March 2015

Banook Group - New branding announcement

Cardiabase/Banook Central Imaging becomes Banook Group - New branding announcement.
Read the full post
March 2014

Webinar: Imaging anti-cancer treatment response at a preclinical and clinical stage

Use of imaging in oncology clinical trials is mainly based on morphological evaluation…
Read the full post
Expertises > Readers & adjudicators

Readers & adjudicators

We have assembled a team of experienced readers, both in Europe and US, with a proven and comprehensive track record in several therapeutic areas.


All readers assigned to the review of data collected during a study meet the following requirements:


  • Prior extensive experience with data reading (>5 years) including knowledge and familiarity with clinical trial good practices and regulatory requirements,
  • Prior specific experience in performing the ECG or imaging analyses required as per protocol (according to Banook Group SOPs for physician qualification).

Our board-certified experts deliver a timely, accurate, and comprehensive analysis of all clinical data. Each new member of the readers’ team receives extensive and rigorous training in image reading, clinical trial requirements and data management procedures and timelines with the main objective to reduce variability in data assessments throughout study conduct.


Our standard process is to involve one or more reading teams in the study depending on the size of the study, its design and the defined timelines. Upon request, we can involve our medical reviewers in the data readings as adjudicators, more particularly to review pre-specified alerts.